↓ Skip to main content

Treatment for primary hypothyroidism: current approaches and future possibilities

Overview of attention for article published in Drug Design, Development and Therapy, December 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)

Mentioned by

blogs
2 blogs
twitter
2 X users
patent
1 patent
facebook
3 Facebook pages
wikipedia
14 Wikipedia pages
video
1 YouTube creator

Citations

dimensions_citation
107 Dimensions

Readers on

mendeley
352 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Treatment for primary hypothyroidism: current approaches and future possibilities
Published in
Drug Design, Development and Therapy, December 2011
DOI 10.2147/dddt.s12894
Pubmed ID
Authors

Ali J Chakera, Simon HS Pearce, Bijay Vaidya

Abstract

Primary hypothyroidism is the most common endocrine disease. Although the diagnosis and treatment of hypothyroidism is often considered simple, there are large numbers of people with this condition who are suboptimally treated. Even in those people with hypothyroidism who are biochemically euthyroid on levothyroxine replacement there is a significant proportion who report poorer quality of life. This review explores the historical and current treatment options for hypothyroidism, reasons for and potential solutions to suboptimal treatment, and future possibilities in the treatment of hypothyroidism.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 352 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 3 <1%
India 1 <1%
Canada 1 <1%
Unknown 347 99%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 96 27%
Student > Master 47 13%
Student > Postgraduate 34 10%
Researcher 23 7%
Student > Doctoral Student 21 6%
Other 51 14%
Unknown 80 23%
Readers by discipline Count As %
Medicine and Dentistry 110 31%
Agricultural and Biological Sciences 48 14%
Biochemistry, Genetics and Molecular Biology 28 8%
Nursing and Health Professions 28 8%
Pharmacology, Toxicology and Pharmaceutical Science 17 5%
Other 33 9%
Unknown 88 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 22. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 December 2022.
All research outputs
#1,746,249
of 25,541,640 outputs
Outputs from Drug Design, Development and Therapy
#77
of 2,273 outputs
Outputs of similar age
#11,404
of 246,826 outputs
Outputs of similar age from Drug Design, Development and Therapy
#2
of 4 outputs
Altmetric has tracked 25,541,640 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,273 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.2. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 246,826 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 4 others from the same source and published within six weeks on either side of this one. This one has scored higher than 2 of them.